Sedation at the end of life

Authors

  • Camilo Rada Ortega Universidad CES
  • Lina Maria Perez toro Universidad CES
  • Sara Echeverri Saldarriaga Universidad CES
  • Diana Carolina Reyes Marquez Universidad CES

Abstract

Life expectancy has increased; consequently, the incidence of chronic illness has risen. Oncologic patients may present in their final days of life severe symptoms refractory to treatment, such as delirium, dyspnea, psychological stress and existential suffering. Sedation at the end of life is a strategy for the relief of those symptoms, highlighting that the intention is not to shorten life. We describe a pharmacological strategy for end-of-life sedation, along with ethics and legal aspects.

 

DOI: http://dx.doi.org/10.21615/cesmedicina.30.1.5

Downloads

Download data is not yet available.

Author Biographies

Camilo Rada Ortega, Universidad CES

Residente Anestesiologia CES

Lina Maria Perez toro, Universidad CES

Residente Anestesiologia CES

Sara Echeverri Saldarriaga, Universidad CES

Residente Anestesiologia CES

Diana Carolina Reyes Marquez, Universidad CES

Residente Anestesiologia CES

Published

2016-06-30

How to Cite

Rada Ortega, C., Perez toro, L. M., Echeverri Saldarriaga, S., & Reyes Marquez, D. C. (2016). Sedation at the end of life. CES Medicina, 30(1), 46–54. Retrieved from https://revistas.ces.edu.co/index.php/medicina/article/view/3383

Issue

Section

Revisión de tema
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views